These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2339365)

  • 1. A new method for the determination of prothrombin in human plasma.
    Hijikata-Okunomiya A
    Thromb Res; 1990 Mar; 57(5):705-15. PubMed ID: 2339365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a synthetic thrombin-inhibitor MD805 on the reaction between thrombin and plasma antithrombin-III.
    Hijikata-Okunomiya A; Okamoto S; Wanaka K
    Thromb Res; 1990 Sep; 59(6):967-77. PubMed ID: 2264021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of prothrombin assay method using MD805 by means of warfarin-treated plasma.
    Hijikata-Okunomiya A; Funahara Y; Opartkiattikul N
    Thromb Res; 1991 Dec; 64(5):559-69. PubMed ID: 1808761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets.
    Sultan Y; Loyer F
    J Lab Clin Med; 1993 Mar; 121(3):444-52. PubMed ID: 8445292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin.
    Tanaka KA; Szlam F; Sun HY; Taketomi T; Levy JH
    Anesth Analg; 2007 Oct; 105(4):933-9, table of contents. PubMed ID: 17898368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sera on thrombin activation rate constants: a one-stage assay for the extrinsic system.
    Baughman DJ; Lytwyn A
    Ann N Y Acad Sci; 1981; 370():822-35. PubMed ID: 6168232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin generation in normal plasma enriched with purified coagulation factors.
    Triantaphyllopoulos DC; Leech SC
    Thromb Res; 1983 Feb; 29(3):355-69. PubMed ID: 6845284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Step Toward Balance: Thrombin Generation Improvement via Procoagulant Factor and Antithrombin Supplementation.
    Mitrophanov AY; Szlam F; Sniecinski RM; Levy JH; Reifman J
    Anesth Analg; 2016 Sep; 123(3):535-46. PubMed ID: 27541717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.
    Ofosu FA; Sie P; Modi GJ; Fernandez F; Buchanan MR; Blajchman MA; Boneu B; Hirsh J
    Biochem J; 1987 Apr; 243(2):579-88. PubMed ID: 2443128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Simultaneous determination of zymogen activation time and zymogen level using chromogenic substrates in blood coagulation analysis].
    Svendsen L; Brogli M; Stocker K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):150-6. PubMed ID: 6177596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative anticoagulant effects of various thrombin inhibitors, as determined in the ecarin clotting time method.
    Callas DD; Fareed J
    Thromb Res; 1996 Sep; 83(6):463-8. PubMed ID: 8885140
    [No Abstract]   [Full Text] [Related]  

  • 14. Higher concentrations of heparin and hirudin are required to inhibit thrombin generation in tissue factor-activated cord plasma than in adult plasma.
    Baier K; Cvirn G; Fritsch P; Köstenberger M; Gallistl S; Leschnik B; Muntean W
    Pediatr Res; 2005 May; 57(5 Pt 1):685-9. PubMed ID: 15718352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.
    Boisclair MD; Lane DA; Philippou H; Sheikh S; Hunt B
    Thromb Haemost; 1993 Aug; 70(2):253-8. PubMed ID: 8236130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions.
    Kretz CA; Cuddy KK; Stafford AR; Fredenburgh JC; Roberts R; Weitz JI
    Thromb Haemost; 2010 Jan; 103(1):83-93. PubMed ID: 20062917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: an in vitro study.
    Dargaud Y; Desmurs-Clavel H; Marin S; Bordet JC; Poplavsky JL; Negrier C
    J Thromb Haemost; 2008 Jun; 6(6):962-8. PubMed ID: 18373620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor IX from prothrombin complex concentrate augments low dose tissue factor-triggered thrombin generation in vitro.
    Hasan S; Abuelkasem E; Williams B; Henderson R; Mazzeffi MA; Tanaka KA
    Br J Anaesth; 2018 Oct; 121(4):936-943. PubMed ID: 30236256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin.
    Berry CN; Girardot C; Lecoffre C; Lunven C
    Thromb Haemost; 1994 Sep; 72(3):381-6. PubMed ID: 7855788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of factor V during intrinsic and extrinsic coagulation. Inhibition by heparin, hirudin and D-Phe-Pro-Arg-Ch2Cl.
    Yang XJ; Blajchman MA; Craven S; Smith LM; Anvari N; Ofosu FA
    Biochem J; 1990 Dec; 272(2):399-406. PubMed ID: 2268268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.